Anticancer agent 112
Anticancer agent 112 is a potent anti-cancer agent for cancer research, extracted from patent WO2020198567[1].
Product Specifications
CAS Number
[2495321-37-2]
UNSPSC
12352005
Target
Others
Type
Reference compound
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/anticancer-agent-112.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=CC(C2=NC(C)=C(NCCNC)C=C2)=NC3=CC=C(Cl)C=C13)N(CC4=CN=C(CC)N4C)C
Molecular Formula
C27H32ClN7O
Molecular Weight
506.04
References & Citations
[1]Eamon Comer, et al. Quinoline derivatives and their use for the treatment of cancer. Patent WO2020198567
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
033396-APC 200 µL
CCNB3, phosphorylated (T280) (CCNB3, CYCB3, G2/mitotic-specific cyclin-B3) (APC) discontinued
Ask
View Details 